- Open
- 5.90
- High
- 6.00
- Low
- 5.60
- Close
- 5.75
- Change
- -0.20 (-3.39%)
- Volume
- 3,018,760
| 22 Sept 2026 | 07:00:06 | Board Changes |
| 15 Sept 2026 | 07:01:01 | Interim Results |
| 15 Sept 2026 | 07:00:05 | Chief Financial Officer Succession |
| 8 Sept 2026 | 15:51:25 | Holding(s) in Company |
| 4 Sept 2026 | 07:00:03 | Notice of Results |
| 9 Jun 2026 | Annual Report and Accounts (to 2025-12-31) | |
| 1 Oct 2025 | Annual Report and Accounts (to 2024-12-31) | |
| 8 Oct 2024 | Annual Report and Accounts (to 2023-12-31) |
Hvivo plc acts as a holding company with investments in its wholly owned subsidiaries, hVIVO Services Limited and hVIVO Inc. The primary business activity of hVIVO Services Limited involves conducting human challenge studies and providing laboratory services for clinical trials on behalf of commercial clients. The company serves the biopharmaceutical sector, focusing on accelerating the development of new therapies. It operates primarily in the United Kingdom and has minority investments in associates, including Prep Biopharm Limited and Imutex Limited.
| 22 Sept 2026 | 07:00:06 | Board Changes |
| 15 Sept 2026 | 07:01:01 | Interim Results |
| 15 Sept 2026 | 07:00:05 | Chief Financial Officer Succession |
| 8 Sept 2026 | 15:51:25 | Holding(s) in Company |
| 4 Sept 2026 | 07:00:03 | Notice of Results |
| 9 Jun 2026 | Annual Report and Accounts (to 2025-12-31) | |
| 1 Oct 2025 | Annual Report and Accounts (to 2024-12-31) | |
| 8 Oct 2024 | Annual Report and Accounts (to 2023-12-31) |
Hvivo plc acts as a holding company with investments in its wholly owned subsidiaries, hVIVO Services Limited and hVIVO Inc. The primary business activity of hVIVO Services Limited involves conducting human challenge studies and providing laboratory services for clinical trials on behalf of commercial clients. The company serves the biopharmaceutical sector, focusing on accelerating the development of new therapies. It operates primarily in the United Kingdom and has minority investments in associates, including Prep Biopharm Limited and Imutex Limited.
| Issuer | Mkt cap | 1Y |
|---|---|---|
| £12m | +4.0% | |
| £11m | +0.0% | |
| £11m | +1.0% | |
| £8m | -0.7% | |
HVOHvivo plc | £5m | -0.2% |
| £3m | -0.9% |
| Issuer | Mkt cap | 1Y |
|---|---|---|
| £12m | +4.0% | |
| £11m | +0.0% | |
| £11m | +1.0% | |
| £8m | -0.7% | |
HVOHvivo plc | £5m | -0.2% |
| £3m | -0.9% |
